Techprecision (TPCS) Form 4: 192,500 options at $0.32; 17,086 shares sold
Rhea-AI Filing Summary
On 08/06/2025 Techprecision Corporation CEO Alexander Shen reported insider transactions on a Form 4. The filing shows a grant of 192,500 stock options with a conversion/exercise price of $0.32 and a separate reported disposition of 17,086 common shares at $5.49. The Form displays beneficial ownership figures of 246,879 and 229,793 shares as shown in the filing and identifies the awards as made under the Company’s 2016 Equity Incentive Plan.
The derivative table indicates the 192,500 options are tied to common stock and lists an exercisable date of 08/11/2025. The filing also includes an explanatory note that prior options vested in three cumulative installments: 333,334 shares on 08/12/2015, 333,333 on 08/12/2016, and 333,333 on 08/11/2017. The Form 4 was signed by attorney-in-fact Phillip Podgorski on 08/08/2025.
Positive
- 192,500 stock options granted are explicitly identified in the filing, showing clear disclosure of equity compensation.
- Options granted under the 2016 Equity Incentive Plan, providing a documented plan source for the award.
- Exercisable date of 08/11/2025 for the reported options is stated, giving clarity on timing.
Negative
- Disposition of 17,086 common shares at $5.49 is reported, indicating insider selling on 08/06/2025.
Insights
TL;DR: CEO received 192,500 options at $0.32 and reported a sale of 17,086 shares on 08/06/2025—standard insider compensation and liquidity actions.
The Form 4 documents a sizable option grant under the 2016 Equity Incentive Plan and a contemporaneous sale of common stock. The filing explicitly shows the option exercise/conversion price ($0.32), the number of options (192,500), and a reported share disposition (17,086 shares at $5.49). These are disclosure-driven items that provide transparency on management compensation and insider selling; the filing does not include financial metrics or statements that would change valuations.
TL;DR: Grant documented under the company plan with exercisable date noted and historical vesting schedule disclosed—governance disclosure appears complete.
The Form 4 notes the grant is pursuant to the Company’s 2016 Equity Incentive Plan and supplies an exercisable date (08/11/2025) for the reported options. The filing also reiterates the vesting history of earlier option awards with dates and installment amounts. The Form is executed by an attorney-in-fact and includes signature and filing date, meeting procedural disclosure requirements.